Lunit Inc.

Lunit – Conquer Cancer through AI is an AI-powered healthcare platform focused on cancer detection, treatment prediction, and biomarker research. By enabling early cancer detection and predicting treatment response, Lunit aims to improve patient outcomes and support precision oncology. The solution highlights extensive research with 200+ studies, a global network of healthcare sites, and partnerships with leading institutions and industry players. Lunit emphasizes collaboration with hospitals and researchers across 50+ countries and 3,800 sites, with ongoing news and breakthroughs in AI-assisted cancer care.

How it Works

1. AI-based cancer detection. Analyzes medical imaging and data to identify early-stage cancers and assist radiologists in diagnosis.
2. AI-driven treatment biomarkers. Predicts immunotherapy response and guides personalized treatment plans.
3. Research and partnerships. Collaborates with global research partners and healthcare networks to advance AI biomarker discovery and validation.
4. Clinical deployment. Integrates into hospital workflows and national screening programs to scale access to AI-powered cancer care.

Use Cases

• Early cancer screening and detection in radiology workflows
• Predicting immunotherapy efficacy for better patient stratification
• Biomarker research and validation in oncology
• Collaborative AI studies with academic and industry partners
• Nationwide or multi-site cancer screening programs

Safety, Privacy, and Compliance Considerations

• Designed for clinical use with appropriate regulatory approvals and medical oversight
• Emphasis on data privacy and secure handling of patient data across workflows
• Transparent reporting of AI performance and ongoing validation in real-world settings
• Collaboration with healthcare professionals to ensure responsible integration into care pathways

Core Features

• AI-powered cancer detection to aid early diagnosis
• Biomarker AI for immunotherapy response prediction
• Large-scale research with 200+ studies and abstracts
• Global deployment across 50+ countries and 3,800 sites
• Partnerships with Global Research and Global Business Partners
• News and case studies highlighting real-world implementations
• Multi-language and cross-institution collaboration support
• Secure, compliant integration into clinical workflows